Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-08-06

FDA Approved: ESOMEPRAZOLE STRONTIUM — Original Application (R2 Pharma, LLC)

View source ↗

Summary

FDA approved esomeprazole strontium via the Original Application (NDA202342) for indications consistent with proton pump inhibitors (GERD-related conditions).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esomeprazole strontium (Esomeprazole strontium)

Snippet

ORIG AP for ESOMEPRAZOLE STRONTIUM (ESOMEPRAZOLE STRONTIUM)